Here, we describe models of three distinct, serially transplanted myc-driven and h/mCD22+ lymphoma in immunocompetent TME of C57BL/6 (BL6) mice in which organ-specific TME and efficacy of targeted immunotherapies was characterized. Here, MYC is linked to lymphoma.